Article in Nutrients, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Aidana GabdulkayumLaboratory of Genomic and Personalized Medicine, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.ORCID 0000-0003-1551-3637
Saya AmangeldikyzyThe National Center for Children's Rehabilitation, Astana 010000, Kazakhstan.
Adil YerezhepovDepartment of Biotechnology, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.
Sayipzhamal KhassanovaThe National Center for Sports Medicine and Rehabilitation, Almaty 020000, Kazakhstan.
Kenes R AkilzhanovDepartment of Medicine, Semey Medical University, Pavlodar Branch, Pavlodar 140000, Kazakhstan.ORCID 0000-0002-3342-2424
Ulan KozhamkulovLaboratory of Genomic and Personalized Medicine, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.
Saule RakhimovaLaboratory of Genomic and Personalized Medicine, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.ORCID 0000-0002-8245-2400
Ulykbek KairovLaboratory of Bioinformatics and Systems Biology, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.ORCID 0000-0001-8511-8064
Ainur AkilzhanovaLaboratory of Genomic and Personalized Medicine, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.ORCID 0000-0001-6161-8355
Dauren YerezhepovLaboratory of Genomic and Personalized Medicine, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.ORCID 0000-0002-4161-1348
Funding
Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan BR24992841Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan BR24993023Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan BR27199879Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan АР19680003
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
AthletesPolymorphism, GeneticPolymorphism, Single NucleotideReceptors, CalcitriolVitamin D DeficiencyAdultDeoxyribonucleases, Type II Site-SpecificGenotypeHumansKazakhstanMaleVitamin DYoung AdultDeoxyribonucleases, Type II Site-SpecificReceptors, CalcitriolVDR protein, humanVitamin Dpower athletesVDR FokI polymorphismvitamin D deficiencyvitamin D receptor
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
FokI Polymorphism of the · full record | OpenQuestion